ISM-3412
N/A
Report date: 2026/03/04 20:01:44
NME
Base Information
Drug NameISM-3412
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesInsilico Medicine Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesInsilico Medicine LtdInSilico Medicine Hong Kong Ltd
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A